Pneumococcal Bacteria Vaccine Market - Global Outlook and Forecast 2022-2028

March 2022 | 75 pages | ID: P077AD391856EN
Market Monitor Global

Abstracts

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

This report contains market size and forecasts of Pneumococcal Bacteria Vaccine in global, including the following market information:

Global Pneumococcal Bacteria Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Pneumococcal Bacteria Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Pneumococcal Bacteria Vaccine companies in 2021 (%)

The global Pneumococcal Bacteria Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

PPSV 23 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pneumococcal Bacteria Vaccine include Merck, Sanofi, Sinopharm, Pfizer, Walvax and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumococcal Bacteria Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pneumococcal Bacteria Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pneumococcal Bacteria Vaccine Market Segment Percentages, by Type, 2021 (%)

• PPSV 23
• PCV 13
• PCV 10

Global Pneumococcal Bacteria Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pneumococcal Bacteria Vaccine Market Segment Percentages, by Application, 2021 (%)

• Infant
• Children
• Adult

Global Pneumococcal Bacteria Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Pneumococcal Bacteria Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pneumococcal Bacteria Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Pneumococcal Bacteria Vaccine revenues share in global market, 2021 (%)

Key companies Pneumococcal Bacteria Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Pneumococcal Bacteria Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Sanofi
• Sinopharm
• Pfizer
• Walvax
• GSK

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pneumococcal Bacteria Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pneumococcal Bacteria Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PNEUMOCOCCAL BACTERIA VACCINE OVERALL MARKET SIZE

2.1 Global Pneumococcal Bacteria Vaccine Market Size: 2021 VS 2028
2.2 Global Pneumococcal Bacteria Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pneumococcal Bacteria Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Pneumococcal Bacteria Vaccine Players in Global Market
3.2 Top Global Pneumococcal Bacteria Vaccine Companies Ranked by Revenue
3.3 Global Pneumococcal Bacteria Vaccine Revenue by Companies
3.4 Global Pneumococcal Bacteria Vaccine Sales by Companies
3.5 Global Pneumococcal Bacteria Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pneumococcal Bacteria Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pneumococcal Bacteria Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pneumococcal Bacteria Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Pneumococcal Bacteria Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Pneumococcal Bacteria Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Pneumococcal Bacteria Vaccine Market Size Markets, 2021 & 2028
  4.1.2 PPSV
  4.1.3 PCV
  4.1.4 PCV
4.2 By Type - Global Pneumococcal Bacteria Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Pneumococcal Bacteria Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Pneumococcal Bacteria Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Pneumococcal Bacteria Vaccine Sales & Forecasts
  4.3.1 By Type - Global Pneumococcal Bacteria Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Pneumococcal Bacteria Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Pneumococcal Bacteria Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pneumococcal Bacteria Vaccine Market Size, 2021 & 2028
  5.1.2 Infant
  5.1.3 Children
  5.1.4 Adult
5.2 By Application - Global Pneumococcal Bacteria Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Pneumococcal Bacteria Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Pneumococcal Bacteria Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Pneumococcal Bacteria Vaccine Sales & Forecasts
  5.3.1 By Application - Global Pneumococcal Bacteria Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Pneumococcal Bacteria Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Pneumococcal Bacteria Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pneumococcal Bacteria Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Pneumococcal Bacteria Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Pneumococcal Bacteria Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Pneumococcal Bacteria Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Pneumococcal Bacteria Vaccine Sales & Forecasts
  6.3.1 By Region - Global Pneumococcal Bacteria Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Pneumococcal Bacteria Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Pneumococcal Bacteria Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Pneumococcal Bacteria Vaccine Sales, 2017-2028
  6.4.3 US Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.4.4 Canada Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.4.5 Mexico Pneumococcal Bacteria Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Pneumococcal Bacteria Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Pneumococcal Bacteria Vaccine Sales, 2017-2028
  6.5.3 Germany Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.5.4 France Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.5.5 U.K. Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.5.6 Italy Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.5.7 Russia Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.5.9 Benelux Pneumococcal Bacteria Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Pneumococcal Bacteria Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Pneumococcal Bacteria Vaccine Sales, 2017-2028
  6.6.3 China Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.6.4 Japan Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.6.5 South Korea Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.6.7 India Pneumococcal Bacteria Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Pneumococcal Bacteria Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Pneumococcal Bacteria Vaccine Sales, 2017-2028
  6.7.3 Brazil Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.7.4 Argentina Pneumococcal Bacteria Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Pneumococcal Bacteria Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Pneumococcal Bacteria Vaccine Sales, 2017-2028
  6.8.3 Turkey Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.8.4 Israel Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Pneumococcal Bacteria Vaccine Market Size, 2017-2028
  6.8.6 UAE Pneumococcal Bacteria Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Pneumococcal Bacteria Vaccine Major Product Offerings
  7.1.4 Merck Pneumococcal Bacteria Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Merck Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Pneumococcal Bacteria Vaccine Major Product Offerings
  7.2.4 Sanofi Pneumococcal Bacteria Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Sanofi Key News
7.3 Sinopharm
  7.3.1 Sinopharm Corporate Summary
  7.3.2 Sinopharm Business Overview
  7.3.3 Sinopharm Pneumococcal Bacteria Vaccine Major Product Offerings
  7.3.4 Sinopharm Pneumococcal Bacteria Vaccine Sales and Revenue in Global (2017-2022)
  7.3.5 Sinopharm Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Pneumococcal Bacteria Vaccine Major Product Offerings
  7.4.4 Pfizer Pneumococcal Bacteria Vaccine Sales and Revenue in Global (2017-2022)
  7.4.5 Pfizer Key News
7.5 Walvax
  7.5.1 Walvax Corporate Summary
  7.5.2 Walvax Business Overview
  7.5.3 Walvax Pneumococcal Bacteria Vaccine Major Product Offerings
  7.5.4 Walvax Pneumococcal Bacteria Vaccine Sales and Revenue in Global (2017-2022)
  7.5.5 Walvax Key News
7.6 GSK
  7.6.1 GSK Corporate Summary
  7.6.2 GSK Business Overview
  7.6.3 GSK Pneumococcal Bacteria Vaccine Major Product Offerings
  7.6.4 GSK Pneumococcal Bacteria Vaccine Sales and Revenue in Global (2017-2022)
  7.6.5 GSK Key News

8 GLOBAL PNEUMOCOCCAL BACTERIA VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Pneumococcal Bacteria Vaccine Production Capacity, 2017-2028
8.2 Pneumococcal Bacteria Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pneumococcal Bacteria Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PNEUMOCOCCAL BACTERIA VACCINE SUPPLY CHAIN ANALYSIS

10.1 Pneumococcal Bacteria Vaccine Industry Value Chain
10.2 Pneumococcal Bacteria Vaccine Upstream Market
10.3 Pneumococcal Bacteria Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Pneumococcal Bacteria Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Pneumococcal Bacteria Vaccine in Global Market
Table 2. Top Pneumococcal Bacteria Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pneumococcal Bacteria Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pneumococcal Bacteria Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Pneumococcal Bacteria Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Pneumococcal Bacteria Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pneumococcal Bacteria Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Pneumococcal Bacteria Vaccine Product Type
Table 9. List of Global Tier 1 Pneumococcal Bacteria Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumococcal Bacteria Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pneumococcal Bacteria Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pneumococcal Bacteria Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pneumococcal Bacteria Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Pneumococcal Bacteria Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pneumococcal Bacteria Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pneumococcal Bacteria Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pneumococcal Bacteria Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Pneumococcal Bacteria Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pneumococcal Bacteria Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pneumococcal Bacteria Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pneumococcal Bacteria Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Pneumococcal Bacteria Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pneumococcal Bacteria Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Pneumococcal Bacteria Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pneumococcal Bacteria Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Pneumococcal Bacteria Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pneumococcal Bacteria Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Pneumococcal Bacteria Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pneumococcal Bacteria Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Pneumococcal Bacteria Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pneumococcal Bacteria Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Pneumococcal Bacteria Vaccine Sales, (K Units), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Pneumococcal Bacteria Vaccine Product Offerings
Table 48. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sanofi Corporate Summary
Table 50. Sanofi Pneumococcal Bacteria Vaccine Product Offerings
Table 51. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Sinopharm Corporate Summary
Table 53. Sinopharm Pneumococcal Bacteria Vaccine Product Offerings
Table 54. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Pneumococcal Bacteria Vaccine Product Offerings
Table 57. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Walvax Corporate Summary
Table 59. Walvax Pneumococcal Bacteria Vaccine Product Offerings
Table 60. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. GSK Corporate Summary
Table 62. GSK Pneumococcal Bacteria Vaccine Product Offerings
Table 63. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Pneumococcal Bacteria Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Pneumococcal Bacteria Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Pneumococcal Bacteria Vaccine Production by Region, 2017-2022 (K Units)
Table 67. Global Pneumococcal Bacteria Vaccine Production by Region, 2023-2028 (K Units)
Table 68. Pneumococcal Bacteria Vaccine Market Opportunities & Trends in Global Market
Table 69. Pneumococcal Bacteria Vaccine Market Drivers in Global Market
Table 70. Pneumococcal Bacteria Vaccine Market Restraints in Global Market
Table 71. Pneumococcal Bacteria Vaccine Raw Materials
Table 72. Pneumococcal Bacteria Vaccine Raw Materials Suppliers in Global Market
Table 73. Typical Pneumococcal Bacteria Vaccine Downstream
Table 74. Pneumococcal Bacteria Vaccine Downstream Clients in Global Market
Table 75. Pneumococcal Bacteria Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Pneumococcal Bacteria Vaccine Segment by Type
Figure 2. Pneumococcal Bacteria Vaccine Segment by Application
Figure 3. Global Pneumococcal Bacteria Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pneumococcal Bacteria Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pneumococcal Bacteria Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Pneumococcal Bacteria Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pneumococcal Bacteria Vaccine Revenue in 2021
Figure 9. By Type - Global Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pneumococcal Bacteria Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pneumococcal Bacteria Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
Figure 19. US Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
Figure 33. China Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pneumococcal Bacteria Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pneumococcal Bacteria Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pneumococcal Bacteria Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pneumococcal Bacteria Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Pneumococcal Bacteria Vaccine by Region, 2021 VS 2028
Figure 50. Pneumococcal Bacteria Vaccine Industry Value Chain
Figure 51. Marketing Channels